Summary
No AI-generated prescribing-information claims were provided to evaluate; the response appears to assess absence/unverifiability rather than making label-consistent or label-inconsistent statements.
Category Scores
Accurate Statements
Unsupported Statements
The result indicates 'absent_from_the_label' / 'invalid_request_or_unverifiable' due to lack of a specific medical claim.
This is not a claim about piroxicam labeling content (indication, dosing, contraindications, warnings, interactions, etc.), so it cannot be verified as label-supported or label-contradicted based on the provided label excerpts.
Contradictions
Important Omissions
No substantive FDA-label-aligned content (e.g., indication(s), recommended dose, contraindications, boxed/warnings, aspirin interaction, nursing-mother recommendation, adverse reactions) was provided in an evaluable form.
Importance:
High
Safety Assessment
Potential Patient Risk:
Low
Because there are no drug dosing/safety claims made by the AI response, there is no direct risk from incorrect label content; however, the absence of evaluable prescribing-information content prevents assessment of safe/accurate medication guidance.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Not Aligned
Primary Issue
No substantive AI-generated labeling claims were provided for evaluation; the response only describes unverifiability/absence.
Suggested Improvement
Provide specific patient-facing or clinician-facing statements (e.g., indication, dose and titration guidance, contraindications including CABG peri-operative, cardiovascular and GI warnings, aspirin coadministration guidance, nursing-mother recommendation, and key adverse reactions) so alignment to the supplied label excerpts can be assessed.